Dietary lutein modulates inducible nitric oxide synthase (iNOS) gene and protein expression in mouse macrophage cells (RAW 264.7)

Molecular Nutrition and Food Research

Volumn 51, Issue 3, 2007, Pages 333-340

  Rafi, Mohamed M ^a,b   Shafaie, Yassaman ^a  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Anti inflammatory; iNOS; Lutein; Macrophage; Nitric oxide

Indexed keywords

SPINACIA OLERACEA; ZEA MAYS;

INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; XANTHOPHYLL;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL LINE; DIET; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; MACROPHAGE; MOUSE; POLYACRYLAMIDE GEL ELECTROPHORESIS;

ANIMALS; CELL LINE; DIET; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LIPOPOLYSACCHARIDES; LUTEIN; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RNA, MESSENGER;

EID: 34250184686     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200600170     Document Type: Article

References (42)

1. Krinsky, N.-I., Johnson, E.-J., Carotenoid actions and their relation to health and disease, Mol. Aspects Med. 2005, 26, 459-516.
2. Calvo, M.-M., Lutein: A valuable ingredient of fruit and vegetables, Crit. Rev. Food Sci. Nutr. 2005, 45, 671-696.
3. Tapiero, H., Townsend, D.-M., Tew, K.-D., The role of carotenoids in the prevention of human pathologies, Biomed. Pharmacother. 2004, 58, 100-110.
4. Alves-Rodrigues, A., Shao, A., The science behind lutein, Toxicol. Lett. 2004, 150, 57-83.
5. Santocono, M., Zurria, M., Berrettini, M., Fedeli, D., Falcioni, G., Influence of astaxanthin, zeaxanthin and lutein on DNA damage and repair in UVA-irradiated cells, J. Photochem. Photobiol. B. 2006, 85, 205-215.
6. Mares-Perlman, J.-A., Millen, A.-E., Ficek, T-L., Hankinson, S.-E., The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic disease. Overview, J. Nutr. 2002, 132, 518S-524S.
7. Schalch, W., Cohn, W., Barker, F.-M., Kopeke, W., et al., Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin - the LUXEA (LUtein Xanthophyll Eye Accumulation) study, Arch. Biochem. Biophys. 2007, 458, 128-135.
8. Seddon, J.-M., Ajani, U.-A., Sperduto, R.-D., Hiller, R., et al., Dietary carotenoids, Vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group, JAMA 1994, 272, 1413-1420.
9. Stahl, W., Sies, H., Bioactivity and protective effects of natural carotenoids, Biochim. Biophys. Acta 2005, 1740, 101-107.
10. Moeller, S.-M., Jacques, P.-F., Blumberg, J.-B., The potential role of dietary xanthophylls in Cataract and Age-Related Macular Degeneration, J. Am. Coll. Nutr. 2000, 19, 522S-527S.
11. Lee, E.-H., Faulhaber, D., Hanson, K.-M., Ding, W., et al., Dietary lutein reduces ultraviolet radiation-induced inflammation and immunosuppression, J. Invest. Dermatol. 2004, 122, 510-517.
12. Gonzalez, S., Astner, S., An, W., Goukassian, D., Pathak, M.-A., Dietary lutein/zeaxanthin decreases ultraviolet B-induced epidermal hyperproliferation and acute inflammation in hairless mice, J. Invest. Dermatol. 2003, 121, 399-405.
13. Lahti, A., Lahde, M., Kankaanranta, H., Moilanen, E., Inhibition of extracellular signal-regulated kinase suppresses endotoxin-induced nitric oxide synthesis in mouse macrophages and in human colon epithelial cells, J. Pharmacol. Exp. Ther. 2000, 294, 1188-1194.
14. Moncada, S., Palmer, R.-M., Higgs, E.-A., Nitric oxide: Physiology, pathophysiology, and pharmacology, Pharmacol. Rev. 1991, 43, 109-142.
15. MacMicking, J., Xie, Q.-W., Nathan, C., Nitric oxide and macrophage function, Annu. Rev. Immunol. 1997, 15, 323-350.
16. Xie, Q.-W., Kashiwabara, Y., Nathan, C., Role of transcription factor NFκB/Rel in induction of nitric oxide synthase, J. Biol. Chem. 1994, 269, 4705-4708.
17. Vane, J.-R., Mitchell, J.-A., Appleton, I., Tomlinson, A., et al., Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation, Proc. Natl. Acad. Sci. 1994, 91, 2046-2050.
18. Wink, D.-A., Kasprzak, K.-S., Maragos, C.-M., Elespuru, R.-K., et al., DNA deaminating ability and genotoxicity of nitric oxide and its progenitors, Science 1991, 254, 1001-1003.
19. Lin, Y.-L., Lin, J.-K., (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-κB, Mol. Pharmacol. 1997, 52, 465-472.
20. Bai, S.-K., Lee, S.-J., Na, H.-J., Ha, K.-S., et al., β-Carotene inhibits inflammatory gene expression in lipopolysaccharidestimulated macrophages by suppressing redox-based NF-κB activation, Exp. Mol. Med. 2005, 37, 323-334.
21. Kim, H.-K., Cheon, B.-S., Kim, Y.-H., Kim, S.-Y., Kim, H.-P., Effects of naturally occurring flavonoids in nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationship, Biochem. Pharmacol. 1999, 58, 759-765.
22. Liang, Y.-C., Huang, Y.-T., Tsai, S.-H., Lin-Shiau, S.-Y., et al., Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages, Carcinogenesis 1999, 20, 1945-1952.
23. Sadowska-Krowicka, H., Mannick, E.-E., Oliver, P.-D., Sandoval, M., et al., Genistein and gut inflammation: Role of nitric oxide, Proc. Soc. Exp. Biol. Med. 1998, 217, 351-357.
24. Yadav, P.-N., Liu, Z., Rafi, M.-M., A diarylheptanoid from Lesser galangal (Alpinia officinarum) inhibits proinflammatory mediators via inhibition of mitogen-activated protein kinase, p44/42, and transcription factor nuclear factor-κB, J. Pharmacol. Exp. Ther. 2003, 305, 925-931.
25. Eigler, A., Moeller, J., Endres, S., Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7, J. Immunol. 1995, 154, 4048-4054.
26. Leutenegger, C.-M., Mislin, C.-N., Sigrist, B., Ehrengruber, M.-U., et al., Quantitative real-time PCR for the measurement of feline cytokine mRNA, Vet. Immunol. Immunopathol. 1999, 71, 291-305.
27. U. S. Food and Drug Administration, Agency response letter GRAS notice no. GRN 000140, accessed November 16, 2006, http://www.cfsan.fda.gov/∼rdb/ opa-g140.html.
28. Wang, M., Tsao, R., Zhang, S., Dong, Z., et al., Antioxidant activity, mutagenicity/anti-mutaenicity, and clastogenicity/ anti-clastogenicity of lutein from marigold flower, Food Chem. Toxicol. 2006, 44, 1522-1529.
29. Ritchlin, C.-T., Haas-Smith, S.-A., Li, P., Hicks, D.-G., Schwarz, E.-M., Mechanism of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis, J. Clin. Invest. 2003, 111, 821-831.
30. Guslandi, M., Nitric oxide and inflammatory bowel disease, Eur. J. Clin. Invest. 1998, 28, 904-907.
31. Makarov, S.-S., NF-kappa B as a therapeutic target in chronic inflammation: Recent advances, Mol. Med. Today 2000, 6, 441-448.
32. Tak, P.-P., Firestein, G.-S., NF-κB: A key role in inflammatory disease, J. Clin. Invest. 2001, 107, 7-11.
33. Choi, J.-W., Nitric oxide production is increased in patients with rheumatoid arthritis but does not correlate with laboratory parameters of disease activity, Clin. Chim. Acta. 2003, 336, 83-87.
34. Goodman, J.-E., Hofseth, L.-J., Hussain, P., Harris, C.-C., Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease, Environ. Mol. Mutagen. 2004, 44, 3-9.
35. Vakkala, M., Kahlos, K., Lakari, E., Paakko, P., et al., Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas, Clin. Cancer Res. 2000, 6, 2408-2416.
36. Marrogi, A.-J., Travis, W.-D., Welsh, J.-A., Khan, M.-A., et al., Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma, Clin. Cancer Res. 2000, 6, 4739-4744.
37. Uotila, P., Valve, E., Martikainen, P.-L., Nevalainen, M., et al., Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer, Urol. Res. 2001, 29, 25-28.
38. Swana, H.-S., Smith, S.-D., Perrotta, P.-L., Saito, N., et al., Inducible nitric oxide synthase with transitional cell carcinoma of the bladder, J. Urol. 1999, 161, 630-634.
39. Kojima, M., Morisaki, T., Tsukahara, Y., Uchiyama, A., et al., Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue, J. Surg. Oncol. 1999, 70, 222-229.
40. Massi, D., Franchi, A., Sardi, I., Magnelli, L., et al., Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions, J. Pathol. 2001, 194, 194-200.
41. Lechner, M., Lirk, P., Rieder, J., Inducible nitric oxide synthase (iNOS) in tumor biology: The two sides of the same coin, Semin. Cancer Biol. 2005, 15, 277-289.
42. Liao, C.-H., Sang, S., Liang, Y.-C., Ho, C.-T., Lin, J.-K., Suppression of inducible nitric oxide synthase and cyclooxygenase-2 in downregulating nuclear factor-kappa B pathway by garcinol, Mol. Carcinog. 2004, 41, 140-149.